Battling rising food costs and time constraints, many consumers are seeking more efficient ways to manage their grocery ...

Johnson & Johnson announced today new data from a Phase 1 study evaluating pasritamig (JNJ-78278343), a first-in-class bispecific antibody that activates T-cells to harness the body's immune system ...